GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aprameya Engineering Ltd (NSE:APRAMEYA) » Definitions » Intrinsic Value: Projected FCF

Aprameya Engineering (NSE:APRAMEYA) Intrinsic Value: Projected FCF : ₹0.00 (As of Jun. 05, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Aprameya Engineering Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-05), Aprameya Engineering's Intrinsic Value: Projected FCF is ₹0.00. The stock price of Aprameya Engineering is ₹180.40. Therefore, Aprameya Engineering's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Aprameya Engineering's Intrinsic Value: Projected FCF or its related term are showing as below:

NSE:APRAMEYA's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.54
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Aprameya Engineering Intrinsic Value: Projected FCF Historical Data

The historical data trend for Aprameya Engineering's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprameya Engineering Intrinsic Value: Projected FCF Chart

Aprameya Engineering Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Intrinsic Value: Projected FCF
- - - - -

Aprameya Engineering Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24
Intrinsic Value: Projected FCF - - - - -

Competitive Comparison of Aprameya Engineering's Intrinsic Value: Projected FCF

For the Medical Instruments & Supplies subindustry, Aprameya Engineering's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aprameya Engineering's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Aprameya Engineering's Price-to-Projected-FCF falls into.


;
;

Aprameya Engineering Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Aprameya Engineering  (NSE:APRAMEYA) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Aprameya Engineering's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=180.40/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aprameya Engineering Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Aprameya Engineering's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Aprameya Engineering Business Description

Traded in Other Exchanges
N/A
Address
908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad, GJ, IND, 380015
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units ("ICU"), Neonatal Intensive Care Units ("NICU"), Pediatric Intensive Care Units ("PICU"), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as "Healthcare Infrastructure projects") in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.

Aprameya Engineering Headlines

No Headlines